Light's Criteria for Pleural Effusion Classification
Light's criteria classify a pleural effusion as an exudate if ANY ONE of the following three thresholds is met: pleural fluid-to-serum protein ratio >0.5, pleural fluid-to-serum LDH ratio >0.6, or pleural fluid LDH >0.67 times the upper limit of normal serum LDH. 1
How to Apply Light's Criteria
Step 1: Obtain Simultaneous Samples
- Collect pleural fluid via thoracentesis with a 21-gauge needle and 50 mL syringe 2
- Draw serum at the same time—simultaneous collection is mandatory for accurate ratio calculations 1
- Send both samples for protein and LDH measurement 2, 1
Step 2: Calculate the Three Ratios
- Protein ratio: pleural fluid protein ÷ serum protein 1
- LDH ratio: pleural fluid LDH ÷ serum LDH 1
- Absolute pleural fluid LDH: compare to 0.67 × upper limit of normal serum LDH 1
Step 3: Interpret the Results
- If ANY ONE criterion is positive → classify as exudate 1
- If ALL THREE criteria are negative → classify as transudate 1
- Meeting just one threshold is sufficient to label the effusion exudative 1
Performance Characteristics
- Sensitivity: 98% for detecting exudates—excellent at ruling out exudates when negative 1, 3
- Specificity: 72–80%—approximately 25–30% of cardiac or hepatic transudates are misclassified as exudates, especially in patients on diuretics 1, 3
- Positive likelihood ratio = 3.5; negative likelihood ratio = 0.03 1
When Serum Is Unavailable
- Use an "or" rule combining pleural fluid LDH >67% of upper limit of normal serum LDH AND pleural fluid cholesterol >55 mg/dL—this provides discriminative capacity comparable to standard Light's criteria 1
- Alternatively, use abbreviated Light's criteria (omitting the LDH ratio) with sensitivity 95.4% and specificity 83.3% 4
Correcting Misclassification in Diuretic-Treated Patients
When to Suspect a False-Positive Exudate
- Clinical picture strongly suggests heart failure or cirrhosis 1, 3
- Patient is receiving diuretic therapy—the most common cause of misclassification 1
- Bilateral effusions in a patient with known heart failure 2
Re-Classification Tools
- Serum-effusion albumin gradient (SEAG): Calculate serum albumin − pleural fluid albumin. SEAG >1.2 g/dL indicates a transudate with 97.5% accuracy and reclassifies ~80% of false-positive exudates 1, 5
- Albumin ratio: Pleural fluid albumin ÷ serum albumin <0.6 also indicates a transudate 1
- NT-proBNP: Pleural fluid or serum NT-proBNP >1500 pg/mL confirms heart failure etiology (serum: 92% sensitivity, 88% specificity; pleural fluid: 94% sensitivity, 91% specificity) 1
Critical Pitfalls to Avoid
- Diuretic therapy concentrates pleural fluid and makes transudates appear exudative—always consider SEAG or NT-proBNP in these patients 1
- Analytical platform variability causes up to 18% discordance in classification between different laboratory analyzers, particularly affecting LDH measurements 6
- Do not aspirate bilateral effusions in clinically obvious transudates (e.g., heart failure, hypoalbuminemia) unless atypical features are present or the effusion fails to respond to therapy 2, 7
- Protein gradient alone correctly diagnoses only ~66% of diuretic-treated cases, whereas the albumin gradient remains reliable 1
When Light's Criteria Should Be Used
- Apply Light's criteria when pleural fluid protein is between 25 and 35 g/L—this borderline range requires formal criteria for accurate differentiation 2
- If pleural fluid protein is <25 g/L and serum protein is normal, the effusion is a transudate without needing Light's criteria 2
- If pleural fluid protein is >35 g/L, the effusion is an exudate without needing Light's criteria 2
Clinical Implications After Classification
- Transudates (>80% due to heart failure): Treat the underlying cause (diuretics, afterload reduction); no further invasive testing needed unless atypical features or treatment failure 1
- Exudates: Require additional diagnostic workup—cytology (detects 60% of malignancies), microbiology (Gram stain, culture in sterile vials AND blood culture bottles), pH measurement if infection suspected, and contrast-enhanced CT with fluid present to guide pleural biopsy if initial tests are nondiagnostic 2, 7